Comparison of Allplex™ SARS-CoV-2 Assay, Easy SARS-CoV-2 WE and Lumipulse quantitative SARS-CoV-2 antigen test performance using automated systems for the diagnosis of COVID-19
- PMID: 34597768
- PMCID: PMC8479447
- DOI: 10.1016/j.ijid.2021.09.069
Comparison of Allplex™ SARS-CoV-2 Assay, Easy SARS-CoV-2 WE and Lumipulse quantitative SARS-CoV-2 antigen test performance using automated systems for the diagnosis of COVID-19
Abstract
Diagnostic methods based on SARS-CoV-2 antigen detection are a promising alternative to SARS-CoV-2 RNA amplification. We evaluated the automated chemiluminescence-based Lumipulse® G SARS-CoV-2 Ag assay as compared to real time assays (combined results from RT-PCR Allplex™ SARS-CoV-2 assay and Easy SARS-CoV-2 WE kit) on 513 nasopharyngeal swabs (NPS). Among these, 53.6% resulted positive to RT-PCR, considered as the reference test. Compared to the reference test, overall sensitivity and specificity of Lumipulse® G SARS-CoV-2 Ag assay were 84.0%, and 89.1%, respectively, and overall agreement between the antigen and molecular assays was substantial (κ = 0.727). When stratifying samples into groups based on ranges of RT-PCR cycle threshold (Ct), the antigen test sensitivity was >95% for samples with Ct <30. Linear regression analysis showed strong and highly significant correlation between the Lumipulse Ag concentrations and the RT-PCR Ct values (RdRp gene), irrespective of whether the Ct values from molecular test were combined in a unique regression analysis or analysed separately. Overall, chemiluminescence-based antigen assay may be reliably applied to NPS samples to identify individuals with high viral loads, more likely to transmit the virus.
Keywords: Antigen assay; COVID-19; Lumipulse; RT-PCR; SARS-CoV-2.
Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures

Similar articles
-
Lumipulse G SARS-CoV-2 Ag assay evaluation using clinical samples from different testing groups.Clin Chem Lab Med. 2021 Apr 7;59(8):1468-1476. doi: 10.1515/cclm-2021-0182. Print 2021 Jul 27. Clin Chem Lab Med. 2021. PMID: 33823089
-
Saliva Is a Valid Alternative to Nasopharyngeal Swab in Chemiluminescence-Based Assay for Detection of SARS-CoV-2 Antigen.J Clin Med. 2021 Apr 2;10(7):1471. doi: 10.3390/jcm10071471. J Clin Med. 2021. PMID: 33918294 Free PMC article.
-
Comparison of Roche and Lumipulse quantitative SARS-CoV-2 antigen test performance using automated systems for the diagnosis of COVID-19.Int J Infect Dis. 2021 Jul;108:263-269. doi: 10.1016/j.ijid.2021.05.067. Epub 2021 Jun 1. Int J Infect Dis. 2021. PMID: 34082089 Free PMC article.
-
Comparison of automated SARS-CoV-2 antigen test for COVID-19 infection with quantitative RT-PCR using 313 nasopharyngeal swabs, including from seven serially followed patients.Int J Infect Dis. 2020 Oct;99:397-402. doi: 10.1016/j.ijid.2020.08.029. Epub 2020 Aug 12. Int J Infect Dis. 2020. PMID: 32800855 Free PMC article.
-
Fujirebio Lumipulse SARS-CoV-2 antigen immunoassay: pooled analysis of diagnostic accuracy.Diagnosis (Berl). 2022 Mar 15;9(2):149-156. doi: 10.1515/dx-2022-0021. Diagnosis (Berl). 2022. PMID: 35287253 Review.
Cited by
-
SARS-CoV-2 N-Antigen Quantification in Respiratory Tract, Plasma and Urine: Kinetics and Association with RT-qPCR Results.Viruses. 2023 Apr 24;15(5):1041. doi: 10.3390/v15051041. Viruses. 2023. PMID: 37243128 Free PMC article.
-
Angiotensin-Converting Enzyme 2-Based Biosensing Modalities and Devices for Coronavirus Detection.Biosensors (Basel). 2022 Nov 7;12(11):984. doi: 10.3390/bios12110984. Biosensors (Basel). 2022. PMID: 36354493 Free PMC article. Review.
-
Clinical accuracy of instrument-based SARS-CoV-2 antigen diagnostic tests: a systematic review and meta-analysis.Virol J. 2024 Apr 29;21(1):99. doi: 10.1186/s12985-024-02371-5. Virol J. 2024. PMID: 38685117 Free PMC article.
-
Diagnostic Performance of Automated SARS-CoV-2 Antigen Assay in Nasal Swab during COVID-19 Vaccination Campaign.Diagnostics (Basel). 2021 Nov 15;11(11):2110. doi: 10.3390/diagnostics11112110. Diagnostics (Basel). 2021. PMID: 34829457 Free PMC article.
-
The Detection of SARS-CoV2 Antigen in Wastewater Using an Automated Chemiluminescence Enzyme Immunoassay.Int J Environ Res Public Health. 2022 Jun 24;19(13):7783. doi: 10.3390/ijerph19137783. Int J Environ Res Public Health. 2022. PMID: 35805441 Free PMC article.
References
-
- Hirotsu Y, Maejima M, Shibusawa M, Amemiya K, Nagakubo Y, Hosaka K, et al. Prospective study of 1308 nasopharyngeal swabs from 1033 patients using the LUMIPULSE SARS-CoV-2 antigen test: Comparison with RT-qPCR. Int J Infect Dis. Apr 2021;105:7–14. doi: 10.1016/j.ijid.2021.02.005. - DOI - PMC - PubMed
-
- Hirotsu Y, Sugiura H, Maejima M, Hayakawa M, Mochizuki H, Tsutsui T, et al. Comparison of Roche and Lumipulse quantitative SARS-CoV-2 antigen test performance using automated systems for the diagnosis of COVID-19. Int J Infect Dis. Jun 1 2021;108:263–269. doi: 10.1016/j.ijid.2021.05.067. - DOI - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous